NMIMC
MYGN icon

Northwestern Mutual Investment Management Company’s Myriad Genetics MYGN Stock Holding History

Northwestern Mutual Investment Management Company’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-7,260
Closed -$257K – 885
2015
Q1 		$257K Buy
+7,260
New +$260K 0.01% 730

Other funds holding MYGN

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northwestern Mutual Investment Management Company's MYGN Position: Q2 2015 in Review

Northwestern Mutual Investment Management Company sold out of Myriad Genetics (MYGN) in Q2 2015, closing a stake of 7,260 shares — an estimated $257K sold.

Northwestern Mutual Investment Management Company first reported a position in MYGN in Q1 2015 and held it in 1 quarter. The position peaked at $257K in Q1 2015. 235 funds tracked by Wall St. Rank hold MYGN as of Q2 2015.

  • Northwestern Mutual Investment Management Company reported no remaining Myriad Genetics position as of Q2 2015 after selling out during the quarter.
  • Northwestern Mutual Investment Management Company sold 7,260 Myriad Genetics shares in Q2 2015, an estimated $257K.
  • Northwestern Mutual Investment Management Company first reported a position in Myriad Genetics in Q1 2015 and held it in 1 quarter.
  • Northwestern Mutual Investment Management Company's Myriad Genetics position peaked at $257K in Q1 2015.
  • 235 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2015.

Based on Northwestern Mutual Investment Management Company's 13F filing for Q2 2015, filed 14 Aug 2015.